Adovate
Biopharmaceutical company developing drug candidates that target adenosine receptors. Uses a next-generation adenosine drug discovery platform to design patented small-molecule compounds with optimized physicochemical properties and distribution kinetics to enable target-tissue delivery.
Industries
biotechnology
pharmaceutical
test-and-measurement
Nr. of Employees
small (1-50)
Patents
Products
Adenosine receptor-targeted drug candidates
Discovery-stage small-molecule therapeutic candidates designed to target adenosine receptors with optimized physicochemical properties and distribution kinetics to enhance tissue exposure.
Adenosine receptor-targeted drug candidates
Discovery-stage small-molecule therapeutic candidates designed to target adenosine receptors with optimized physicochemical properties and distribution kinetics to enhance tissue exposure.
Expertise Areas
- Adenosine receptor drug discovery
- Small-molecule medicinal chemistry
- Physicochemical property optimization
- Pharmacokinetics and biodistribution optimization
Key Technologies
- Adenosine receptor targeting
- Small-molecule design
- Physicochemical property optimization
- Pharmacokinetic/biodistribution profiling
News & Updates
The company states its platform enables design of patented compounds with optimized physicochemical characteristics and distribution kinetics.
The company states its platform enables design of patented compounds with optimized physicochemical characteristics and distribution kinetics.